Fabry's disease: Difference between revisions

Jump to navigation Jump to search
Michael Maddaleni (talk | contribs)
Michael Maddaleni (talk | contribs)
Line 33: Line 33:


==[[Fabry's disease epidemiology and demographics|Epidemiology and Demographics]]==
==[[Fabry's disease epidemiology and demographics|Epidemiology and Demographics]]==
==[[Fabry's disease risk factors|Risk Factors]]==
==[[Fabry's disease screening|Screening]]==
==[[Fabry's disease natural history, complications and prognosis|Natural History, Complications and Prognosis]]


==Diagnosis==
==Diagnosis==

Revision as of 20:00, 22 August 2012

Template:DiseaseDisorder infobox

Fabry's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fabry's disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fabry's disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fabry's disease

CDC on Fabry's disease

Fabry's disease in the news

Blogs on Fabry's disease

Directions to Hospitals Treating Fabry's disease

Risk calculators and risk factors for Fabry's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Synonyms and keywords: Anderson-Fabry disease; angiokeratoma corporis diffusum universale; alpha-galactosidase A deficiency; ceramide trihexosidase deficiency; hereditary dystopic lipidosis; GLA deficiency; Sweeley-Klionsky disease

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

==Natural History, Complications and Prognosis

Diagnosis

Treatment

External links

Template:WikiDoc Sources